An intriguing new study being published in next month’s issue of the journal Critical Care Medicine, and published online early by the National Institute of Health, has found that cannabinoid-based medicine administered through IV may provide a method of helping an individual resuscitate from cardiac arrest.
According to researchers, who examined rate models of cardiac arrest, “Blood temperatures decreased from 37°C to 33°C in 4 hours in animals in WIN55, 212-2 [cannabinoid receptor agonist] hypothermia group.. There was a significant improvement in myocardial function in the animals treated with WIN55, 212-2 hypothermia beginning at 1 hour after start of infusion.”
They continue; “WIN55, 212-2 hypothermia group was associated with significantly improved neurologic deficit scores and survival time when compared with placebo control group and WIN55, 212-2 with normal body temperature group.”
They conclude that; “In a rat model of cardiac arrest, better postresuscitation myocardial function, neurological deficit scores, and longer duration of survival were observed by the pharmacologically induced hypothermia with WIN55, 212-2. The improved outcomes of cardiopulmonary resuscitation following administration of WIN55, 212-2 appeared to be the results from its temperature reduction effects.”
The study can be found here:
This study was conducted by researchers at the Weil Institute of Critical Care Medicine, and the Keck School of Medicine at the University of Southern California.